Invention relates to a System for measuring glycated hemoglobin, comprises a microfluidic coupon, at least one capillary channel on the microfluidic coupon that encloses a solution capable of forming a solution density gradient, a sample well in connection with the capillary channel and configured for adding a sample containing red blood cells. This system obtains HbA1c levels which are red blood cells age specific and thus accurate diagnosis of diabetes.

Invention relates to a novel time dependent pulsed release system containing tablet in capsule for programmed release of drug for targeted delivery particularly salbutamol sulphate for the treatment of nocturnal asthma. Composition comprises impermeable capsule body and a soluble cap and at least two tablet formulations of which one is uncoated tablet comprising drug with pharmaceutical excipients that releases first pulse of drug as immediate release and another tablet that releases second pulse of drug as delayed release.

Invention relates to herbal composition for treatment of inflammation and arthritis comprising extract of at least one bioactive portion and/or powder of one or more medicinal herbs such as Sesbania grandiflora, Sesbania sesban and Terminalia chebula. This composition has no side effects, safe, has a long shelf life, inexpensive, and cost effective.

Invention relates to pharmaceutical formulation for enhancing the oral bioavailability of a prodrug ester as a non-aqueous formulation by formulating the ester prodrug such as Cefuroxime axetil with medium chain triglycerides. The prodrug is selected from antibiotics, corticosteroids, Non-Steroidal anti-inflammatory drugs, Anti-retroviral and Angiotensin II antagonists. The Preparation method is simple, cost effective, practical and reproducible for enhancement of the bioavailability.

Invention relates to site specific formulation for effective treatment of cancer. Proliposomal formulation for effective treatment of cancer comprises therapeutically effective amount of anticancer agent, phospholipids, cholesterol and coating polymer. The anticancer agent is paclitaxel , and the phospholipids are egg phosphatidylglycerol and distearoyl phosphatidylcholine.

The invention relates to Preparation of anhydrous rare earth metal halides from their hydrates comprises preparing slurry of rare earth metal halide hydrate in an organic solvent, refluxing and azeotropic distillation for quantitative removal of surface and bond water. This prepared anhydrous rare earth metal halides particularly halides and more specifically anhydrous cerium chloride has wide range of applications in electrochemical reduction process for production of metal and as catalyst in the addition of organometallic to carbonyl group to form corresponding alcohols.

For more details about technology: Click here